Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

Phase 4 Completed 51 enrolled Al Hadi Hospital

RandomizedParallel-groupOpen-labelTreatment

Summary

prospective study evaluating the impact of subthreshold micropulsed laser on the number of Aflibercept injections when used as an adjuvant therapy in eyes with diabetic macular edema.

Timeline

Start: 2017-05-08
Primary completion: 2017-06-21
Completion: 2018-12-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aflibercept	Protein / enzyme biologic	2 mg	Intravitreal

Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

Summary

Timeline

Drugs

Indications